The Campo de Calatrava volcanic field: geology and resources.

The volcanic region of Campo de Calatrava, located in South-Central Spain, and in particular in the Ciudad Real Province (Castilla-La Mancha region) is one of the three most important areas with recent volcanic activity in the Iberian Peninsula, together with those of Olot (Gerona, in Catalonia) and Cabo de Gata (Almeria, in Andalucía). In this work we describe succinctly the characteristics of this volcanism, as well as the related iron and manganese (plus minor cobalt) oxides mineralizations. Finally, an also brief description of the legal measures implemented to protect the local volcanic buildings is included

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

Data on convalescent plasma (CP) treatment in COVID-19 outpatients are scarce. We aimed to assess whether CP administered during the first week of symptoms reduced the disease progression or risk of hospitalization of outpatients. Two multicenter, double-blind randomized trials (NCT04621123, NCT04589949) were merged with data pooling starting when = 50 years and symptomatic for <= 7days were included. The intervention consisted of 200-300mL of CP with a predefined minimum level of antibodies. Primary endpoints were a 5-point disease severity scale and a composite of hospitalization or death by 28 days. Amongst the 797 patients included, 390 received CP and 392 placebo; they had a median age of 58 years, 1 comorbidity, 5 days symptoms and 93% had negative IgG antibody-test. Seventy-four patients were hospitalized, 6 required mechanical ventilation and 3 died. The odds ratio (OR) of CP for improved disease severity scale was 0.936 (credible interval (CI) 0.667-1.311); OR for hospitalization or death was 0.919 (CI 0.592-1.416). CP effect on hospital admission or death was largest in patients with <= 5 days of symptoms (OR 0.658, 95%CI 0.394-1.085). CP did not decrease the time to full symptom resolution

La inversión matuyama-brunhes en la secuencia de terrazas del río Jarama entre Velilla de San Antonio y Altos de la Mejorada, al se de Madrid (España

Al Este de la ciudad de Madrid, en el valle del río Jarama y entre Mejorada del Campo y Velilla de San Antonio se han estudiado las propiedades paleomagnéticas de una secuencia de terrazas comprendidas entre El Rasillo y Altos de la Mejorada, a lo largo de la autopista M-203 de reciente construcción. La car- tografía geomorfológica realizada permitió separar además de la llanura aluvial a +4-5 m, terrazas a +20 m, +30-35 m, +60-65 m, +85-90 m, +105-110 m y +125-130 m. De ellas se muestrearon 5 niveles, a excepción de la de +20 m, en taludes frescos de la autovía que permiten situar a las terrazas con altitudes relativas igual o mayores a +60-65 m en el Chron Matuyama, mientras que las terrazas a +20 m y +30-35 m pertenecerían al Chron Brunhes (< 0.780 Ma). Dataciones por ESR en terrazas del valle del río Arlanzón en Burgos (Moreno et al., 2012), sugieren que en el valle del Jarama la inversión Matuyama-Brunhes podría establecerse entre el final de la sedimentación de la terraza a +60-65 m y el encajamiento de la terraza a +50-55 m subsiguiente, representada aguas arriba de Mejorada del Campo, en Marchamalo (Pérez-González, 1994)

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN

Delayed colorectal cancer care during covid-19 pandemic (decor-19). Global perspective from an international survey

Background The widespread nature of coronavirus disease 2019 (COVID-19) has been unprecedented. We sought to analyze its global impact with a survey on colorectal cancer (CRC) care during the pandemic. Methods The impact of COVID-19 on preoperative assessment, elective surgery, and postoperative management of CRC patients was explored by a 35-item survey, which was distributed worldwide to members of surgical societies with an interest in CRC care. Respondents were divided into two comparator groups: 1) ‘delay’ group: CRC care affected by the pandemic; 2) ‘no delay’ group: unaltered CRC practice. Results A total of 1,051 respondents from 84 countries completed the survey. No substantial differences in demographics were found between the ‘delay’ (745, 70.9%) and ‘no delay’ (306, 29.1%) groups. Suspension of multidisciplinary team meetings, staff members quarantined or relocated to COVID-19 units, units fully dedicated to COVID-19 care, personal protective equipment not readily available were factors significantly associated to delays in endoscopy, radiology, surgery, histopathology and prolonged chemoradiation therapy-to-surgery intervals. In the ‘delay’ group, 48.9% of respondents reported a change in the initial surgical plan and 26.3% reported a shift from elective to urgent operations. Recovery of CRC care was associated with the status of the outbreak. Practicing in COVID-free units, no change in operative slots and staff members not relocated to COVID-19 units were statistically associated with unaltered CRC care in the ‘no delay’ group, while the geographical distribution was not. Conclusions Global changes in diagnostic and therapeutic CRC practices were evident. Changes were associated with differences in health-care delivery systems, hospital’s preparedness, resources availability, and local COVID-19 prevalence rather than geographical factors. Strategic planning is required to optimize CRC care